Immunopathogenesis of hepatitis C virus infection: Multifaceted strategies subverting innate and adaptive immunity

Internal Medicine

Volumn 45, Issue 4, 2006, Pages 183-191

  Kanto, Tatsuya ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adaptive immunity; Apoptosis; Dendritic cells; Innate immunity

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; RIBAVIRIN; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; APOPTOSIS; BINDING AFFINITY; CELL MATURATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE MUTATION; HELPER CELL; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LIVER CELL DAMAGE; LYMPHOCYTE DIFFERENTIATION; MOLECULAR MECHANICS; NATURAL KILLER CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; VIRUS GENOME; VIRUS IMMUNITY; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIGEN PRESENTATION; CASPASES; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; FAS LIGAND PROTEIN; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LIVER; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTORS; VIRUS REPLICATION;

EID: 33645038201     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1530     Document Type: Review

References (95)

1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 34: 1225-1241, 2001.
2. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C.. Ann Intern Med 132: 296-305, 2000.
3. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 345: 41-52, 2001.
4. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 38: 4-13, 2003.
5. Su AI, Pezacki JP, Wodicka L, et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 99: 15669-15674, 2002.
6. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19: 65-91, 2001.
7. Frese M, Schwarzle V, Barth K, et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35: 694-703, 2002.
8. Webster GJ, Reignat S, Maini MK, et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32: 1117-1124, 2000.
9. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192: 921-930, 2000.
10. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811, 2000.
11. Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863-869, 2001.
12. Heil F, Ahmad-Nejad P, Hemmi H, et al. The Toll-like receptor 7 (TLR7) -specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 33: 2987-2997, 2003.
13. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2: 151-161, 2002.
14. Liu YJ, Kadowaki N, Rissoan MC, Soumelis V. T cell activation and polarization by DC1 and DC2. Curr Top Microbiol Immunol 251: 149-159, 2000.
15. Day CL, Lauer GM, Robbins GK, et al. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76: 12584-12595, 2002.
16. Hiramatsu N, Hayashi N, Katayama K, et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19: 1354-1359, 1994.
17. Mita E, Hayashi N, Iio S, et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 204: 468-474, 1994.
18. Ray RB, Meyer K, Steele R, Shrivastava A, Aggarwal BB, Ray R. Inhibition of tumor necrosis factor (TNF-alpha) -mediated apoptosis by hepatitis C virus core protein. J Biol Chem 273: 2256-2259, 1998.
19. Honda M, Kaneko S, Shimazaki T, et al. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology 31: 1351-1359, 2000.
20. Hiramatsu N, Hayashi N, Haruna Y, et al. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology 16: 306-311, 1992.
21. Bantel H, Lugering A, Poremba C, et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepafitis C virus infection. Hepatology 34: 758-767, 2001.
22. Ando, K, Hiroishi K, Kaneko T, et al. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 158: 5283-5291, 1997.
23. Gremion C, Grabscheid B, Wolk B, et al. Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction. J Virol 78: 2152-2157, 2004.
24. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194: 1395-1406, 2001.
25. Foy E, Li K, Wang C, et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300: 1145-1148, 2003.
26. Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285: 107-110, 1999.
27. Li K, Foy E, Ferreon JC, et al. Immune evasion by hepatitis C virus NS3/ 4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc, Natl Acad Sci USA 102: 2992-2997, 2005.
28. Foy E, Li K, Sumpter R Jr, et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc, Natl Acad Sci USA 102: 2986-2991, 2005.
29. Khakoo SI, Thio CL, Martin MP, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874, 2004.
30. Jinushi M, Takehara T, Kanto T, et al. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol 170: 1249-1256, 2003.
31. Thimme R, Bukh J, Spangenberg HC, et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA 99: 15661-15668, 2002.
32. Jinushi M, Takehara T, Tatsumi T, et al. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol 173: 6072-6081, 2004.
33. He XS, Rehermann B, Lopez-Labrador FX, et al. Quantitative analysis of hepatitis C virus-specific CD8 (+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 96: 5692-5697, 1999.
34. Lechner F, Wong DK, Dunbar PR, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499-1512, 2000.
35. Gruener NH, Lechner F, Jung MC, et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 75: 5550-5558, 2001.
36. Lauer GM, Barnes E, Lucas M, et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 127: 924-936, 2004.
37. Farci P, Alter HJ, Wong DC, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 91: 7792-7796, 1994.
38. Cooper S, Erickson AL, Adams EJ, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 10: 439-449, 1999.
39. Wertheimer AM, Miner C, Lewinsohn DM, Sasaki AW, Kaufman E, Rosen HR. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 37: 577-589, 2003.
40. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6: 578-582, 2000.
41. Koziel MJ, Wong DK, Dudley D, Houghton M, Walker BD. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis 176: 859-866, 1997.
42. Kamal SM, Amin A, Madwar M, et al. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol 78: 12252-12258, 2004.
43. Scognamiglio P, Accapezzato D, Casciaro MA, et al. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol 162: 6681-6689, 1999.
44. Lai ME, Mazzoleni AP, Argiolu F, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343: 388-390, 1994.
45. Nascimbeni M, Mizukoshi E, Bosmann M, et al. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 77: 4781-4793, 2003.
46. Shoukry NH, Grakoui A, Houghton M, et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 197: 1645-1655, 2003.
47. Grakoui A, Shoukry NH, Woollard DJ, et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662, 2003.
48. Mehta SH, Cox A, Hoover DR, et al. Protection against persistence of hepatitis C. Lancet 359: 1478-1483, 2002.
49. Ulsenheimer A, Gerlach JT, Gruener NH, et al. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 37: 1189-1198, 2003.
50. Hiroishi K, Kita H, Kojima M, et al. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 25: 705-712, 1997.
51. Nelson DR, Marousis CG, Davis GL, et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 158: 1473-1481, 1997.
52. Reherma B, Chang KM McHutchinson J, et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 70: 7092-7102, 1996.
53. Wong DK, Dudley DD, Afdhal NH, et al. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 160: 1479-1488, 1998.
54. Wedemeyer H, He XS, Nascimbeni M, et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169: 3447-3458, 2002.
55. Leroy V, Vigan I, Mosnier JF, et al. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 38: 829-841, 2003.
56. Prezzi C, Casciaro MA, Francavilla V, et al. Virus-specific CD8 (+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur. J Immunol 31: 894-906, 2001.
57. Cox AL, Mosbruger T, Mao Q, et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201: 1741-1752, 2005.
58. Tester I, Smyk-Pearson S, Wang P, et al. Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med 201: 1725-1731, 2005.
59. Timm J, Lauer GM, Kavanagh DG, et al. CD8 epitope escape and reversion in acute HCV infection. J Exp Med 200: 1593-1604, 2004.
60. Seifert U, Liermann H, Racanelli V, et al. Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest 114: 250-259, 2004.
61. Gerlach JT, Diepolder HM, Jung MC, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4 (+) T-cell response in acute hepatitis C. Gastroenterology 117: 933-941, 1999.
62. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G, Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120: 512-524, 2001.
63. Kanto T, Hayashi N, Takehara T, et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 162: 5584-5591, 1999.
64. Kanto T, Inoue M, Miyatake H, et al. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 190: 1919-1926, 2004.
65. Ulsenheimer A, Gerlach JT, Jung MC, et al. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology 41: 643-651, 2005.
66. Goutagny N, Fatmi A, De Ledinghen V, et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 187: 1951-1958, 2003.
67. Kaimori A, Kanto T, Kwang Limn C, et al. Pseudotype hepatitis C virus enters immature myeloid dendritic cells through the interaction with lectin. Virology 324: 74-83, 2004.
68. Longman RS, Talal AH, Jacobson IM, Albert ML, Rice CM. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 103: 1026-1029, 2004.
69. Rollier C, Drexhage JA, Verstrepen BE, et al. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology 38: 851-858, 2003.
70. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS. Interaction between complement receptor gClqR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 106: 1239-1249, 2000.
71. Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 78: 1448-1455, 2004,
72. Crotta S, Stilla A, Wack A, et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195: 35-41, 2002.
73. Sarobe P, Lasarte JJ, Casares N, et al. Abnormal priming of CD4 (+) T cells by dendritic cells expressing hepatitis C virus core and El proteins. J Virol 76: 5062-5070, 2002.
74. Dolganiuc A, Kodys K, Kopasz A, et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immumol 170: 5615-5624, 2003.
75. Brady MT, MacDonald AJ, Rowan AG, Mills KH. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 33: 3448-3457, 2003.
76. Kamal SM, Fehr J, Roesler B, Peters T, Rasenack J-W. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 123: 1070-1083, 2002.
77. Barnes E, Harcourt G, Brown D, et al. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36: 743-754, 2002.
78. Accapezzato D, Francavilla V, Rawson P, et al. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: the role of the virus. Eur J Immunol 34: 438-446, 2004.
79. Francavilla V, Accapezzato D, De Salvo M, et al. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms. Eur J Immunol 34: 427-437, 2004.
80. Appay V, Dunbar PR, Callan M, et al. Memory CD8+ T cells vary in different persistent virus infections. Nat Med 8: 379-385, 2002.
81. Lucas M, Vargas-Cuero AL, Lauer GM, et al. Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells. J Immunol 172: 1744-1753, 2004.
82. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562, 2004.
83. Cabrera R, Tu Z, Xu Y, et al. An immunomodulatory role for CD4 (+) CD25 (+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062-1071, 2004,
84. Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, Chang KM. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38: 1437-1448, 2003.
85. +CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79: 7860-7867, 2005.
86. Accapezzato D, Francavilla V, Paroli M, et al. Hepatic expansion of a virus-specific regulatory CD8 (+) T cell population in chronic hepatitis C virus infection. J Clin Invest 113: 963-972, 2004.
87. Grabowska AM, Lechner F, Klenerman P, et al. Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur J Immunol 31: 2388-2394, 2001.
88. Penna A, Missale G, Lamonaca V, et al. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C. Hepatology 35: 1225-1236, 2002.
89. Schirren CA, Jung MC, Gerlach JT, et al. Liver-derived hepatitis C virus (HCV)-specific CD4 (+) T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology 32: 597-603, 2000.
90. Crispe IN, Hepatic T. cells and liver tolerance. Nat Rev Immunol 3: 51-62, 2003.
91. Lau AH, Thomson AW. Dendritic cells and immune regulation in the liver. Gut 52: 307-314, 2003.
92. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 98: 1432-1440, 1996.
93. Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118: 346-355, 2000.
94. Kamal SM, Ismail A, Graham CS, et al. Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics. Hepatology 39: 1721-1731, 2004.
95. Rahman F, Heller T, Sobao Y, et al. Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology 40: 87-97, 2004.